索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]任艳艳,李小旋,安金,等.心房颤动与认知功能障碍[J].国际心血管病杂志,2017,04:203-206.
点击复制

心房颤动与认知功能障碍(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年04期
页码:
203-206
栏目:
综述
出版日期:
2017-07-25

文章信息/Info

Title:
-
作者:
任艳艳; 李小旋; 安金; 吕佩源
050051 石家庄,河北医科大学附属河北省人民医院神经内科(任艳艳,李小旋,吕佩源); 075000 张家口,河北北方学院(安 金)
Author(s):
-
关键词:
心房颤动; 认知; 无症状性脑梗死; 抗凝; 射频消融术
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.04.004
文献标识码:
-
摘要:
心房颤动(房颤)可影响认知功能。房颤导致血栓形成及脱落造成脑卒中,可影响认知功能。近年有研究证明,房颤还可能通过大脑低灌注、血管内皮功能异常、无症状性脑梗死、脑白质损害及大脑微出血、血管周围间隙扩大等机制影响认知功能。治疗房颤的抗凝药物、射频消融术也可影响患者的认知功能。
Abstract:
-

参考文献/References

[1] Ball J, Carrington MJ, Stewart S. Mild cognitive impairment in high-risk patients with chronic atrial fibrillation: a forgotten component of clinical management?[J]. Heart, 2013, 99(8):542-547.
[2] Prince M, Bryce R, Albanese E, et al. The global prevalence of dementia: a systematic review and metaanalysis[J]. Alzheimers Dement, 2013, 9(1):63-75.
[3] Bunch TJ, Weiss JP, Crandall BG, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia[J]. Heart Rhythm, 2010, 7(4):433-437.
[4] Udompanich S, Lip GY, Apostolakis S, et al. Atrial fibrillation as a risk factor for cognitive impairment: a semi-systematic review[J]. QJM, 2013, 106(9):795-802.
[5] Marzona I, O'Donnell M, Teo K, et al. Increased risk of cognitive and functional decline in patients with atrial fibrillation: results of the ONTARGET and TRANSCEND studies[J]. CMAJ, 2012, 184(6):E329-E336.
[6] O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment[J]. Lancet Neurol, 2003, 2(2):89-98.
[7] January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society[J]. Circulation, 2014, 130(23):2071-2104.
[8] Zhu W, Fu L, Ding Y, et al. Meta-analysis of ATRIA versus CHA2DS2-VASc for predicting stroke and thromboembolism in patients with atrial fibrillation[J]. Int J Cardiol, 2017, 227:436-442.
[9] Cacciatore F, Testa G, Langellotto A, et al. Role of ventricular rate response on dementia in cognitively impaired elderly subjects with atrial fibrillation: a 10-year study[J]. Dement Geriatr Cogn Disord, 2012, 34(3-4):143-148.
[10] Totaro R, Corridoni C, Marini C, et al. Transcranial Doppler evaluation of cerebral blood flow in patients with paroxysmal atrial fibrillation[J]. Ital J Neurol Sci, 1993, 14(6):451-454.
[11] Efimova I, Efimova N, Chernov V, et al. Ablation and pacing: improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates[J]. Pacing Clin Electrophysiol, 2012, 35(3):320-326.
[12] Silverman DH, Phelps ME. Application of positron emission tomography for evaluation of metabolism and blood flow in human brain: normal development, aging, dementia, and stroke[J]. Mol Genet Metab, 2001, 74(1-2):128-138.
[13] Chen LY, Lopez FL, Gottesman RF, et al. Atrial fibrillation and cognitive decline-the role of subclinical cerebral infarcts: the atherosclerosis risk in communities study[J]. Stroke, 2014, 45(9):2568-2574.
[14] Koga H, Takashima Y, Murakawa R, et al. Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals[J]. J Stroke Cerebrovasc Dis, 2009, 18(1):32-37.
[15] Thong JY, Hilal S, Wang Y, et al. Association of silent lacunar infarct with brain atrophy and cognitive impairment[J]. J Neurol Neurosurg Psychiatry, 2013, 84(11):1219-1225.
[16] Kobayashi A, Iguchi M, Shimizu S, et al. Silent cerebral infarcts and cerebral white matter lesions in patients with nonvalvular atrial fibrillation[J]. J Stroke Cerebrovasc Dis, 2012, 21(4):310-317.
[17] Krishnamoorthy S, Lim SH, Lip GY. Assessment of endothelial(dys)function in atrial fibrillation[J]. Ann Med, 2009, 41(8):576-590.
[18] Li J, Solus J, Chen Q, et al. Role of inflammation and oxidative stress in atrial fibrillation[J]. Heart Rhythm, 2010, 7(4):438-444.
[19] Gupta A, Watkins A, Thomas P, et al. Coagulation and inflammatory markers in Alzheimer's and vascular dementia[J]. Int J Clin Pract, 2005, 59(1):52-57.
[20] Marott SC, Nordestgaard BG, Zacho J, et al. Does elevated C-reactive protein increase atrial fibrillation risk? A Mendelian randomization of 47,000 individuals from the general population[J]. J Am Coll Cardiol, 2010, 56(10):789-795.
[21] Kuo HK, Yen CJ, Chang CH, et al. Relation of C-reactive protein to stroke, cognitive disorders, and depression in the general population: systematic review and meta-analysis[J]. Lancet Neurol, 2005, 4(6):371-380.
[22] Wu Y, Chen T. An Up-to-date review on cerebral microbleeds[J]. J Stroke Cerebrovasc Dis, 2016, 25(6):1301-1306.
[23] Akoudad S, Darweesh SK, Leening MJ, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population[J]. Stroke, 2014, 45(11):3436-3439.
[24] Poels MM, Ikram MA, van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study[J]. Neurology, 2012, 78(5):326-333.
[25] Bai M, Yang J, Li Y. Serum N-terminal-pro-brain natriuretic peptide level and its clinical implications in patients with atrial fibrillation[J]. Clin Cardiol, 2009, 32(12):E1-E5.
[26] Vilar-Bergua A, Riba-Llena I, Penalba A, et al. N-terminal pro-brain natriuretic peptide and subclinical brain small vessel disease[J]. Neurology, 2016, 87(24):2533-2539.
[27] Arba F, Quinn TJ, Hankey GJ, et al. Enlarged perivascular spaces and cognitive impairment after stroke and transient ischemic attack[J]. Int J Stroke, 2016, Aug 19.[Epub ahead of print].
[28] Potter GM, Doubal FN, Jackson CA, et al. Enlarged perivascular spaces and cerebral small vessel disease[J]. Int J Stroke, 2015, 10(3):376-381.
[29] Wilke T, Groth A, Mueller S, et al. Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patients[J]. Thromb Haemost, 2012, 107(6):1053-1065.
[30] Moffitt P, Lane DA, Park H, et al. Thromboprophylaxis in atrial fibrillation and association with cognitive decline: systematic review[J]. Age Ageing, 2016, 45(6):767-775.
[31] Mavaddat N, Roalfe A, Fletcher K, et al. Warfarin versus aspirin for prevention of cognitive decline in atrial fibrillation: randomized controlled trial(Birmingham Atrial Fibrillation Treatment of the Aged Study)[J]. Stroke, 2014, 45(5):1381-1386.
[32] Etminan M, Gill S, Samii A. Effect of non-steroidal anti-inflammatory drugs on risk of Alzheimer's disease: systematic review and meta-analysis of observational studies[J]. BMJ, 2003, 327(7407):128.
[33] Flaker GC, Pogue J, Yusuf S, et al. Cognitive function and anticoagulation control in patients with atrial fibrillation[J]. Circ Cardiovasc Qual Outcomes, 2010, 3(3):277-283.
[34] Camm AJ, Lip GY, De Caterina R, et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association[J]. Eur Heart J, 2012, 33(21):2719-2747.
[35] von Bary C, Deneke T, Arentz T, et al. Silent cerebral events as a result of left atrial catheter ablation do not cause neuropsychological sequelae—a MRI-controlled multicenter study[J]. J Interv Card Electrophysiol, 2015, 43(3):217-226.
[36] van Kuilenburg J, Lappegard KT, Sexton J, et al. Persisting thrombin activity in elderly patients with atrial fibrillation on oral anticoagulation is decreased by anti-inflammatory therapy with intensive cholesterol-lowering treatment[J]. J Clin Lipidol, 2011, 5(4):273-280.
[37] Lappegard KT, Pop-Purceleanu M, van Heerde W, et al. Improved neurocognitive functions correlate with reduced inflammatory burden in atrial fibrillation patients treated with intensive cholesterol lowering therapy[J]. J Neuroinflammation, 2013, 10:78.

备注/Memo

备注/Memo:
基金项目: 河北省自然科学基金(H2013307046); 河北省重大医学科研课题项目(zd2013005)
通信作者:吕佩源,Email:peiyuanlu@163.com
更新日期/Last Update: 2017-07-25